← back to search

Anh Tuan Dinh‐Xuan

Guangdong Pharmaceutical University · CN
Area of research
Pulmonary and Respiratory Medicine · Physiology
Research interest
Research interests include Chronic Obstructive Pulmonary Disease (COPD) Research, Asthma and respiratory diseases, Pulmonary Hypertension Research and Treatments, and Nitric Oxide and Endothelin Effects.
h-index
53
citations
15,926
works
430
NIH funding
primary concept
Medicine
email

Recent publications

miR‐30d Attenuates Pulmonary Arterial Hypertension via Targeting MTDH and PDE5A and Modulates the Beneficial Effect of Sildenafil
Advanced Science 2024cited by 4position: middledoi
Collaboration between explainable artificial intelligence and pulmonologists improves the accuracy of pulmonary function test interpretation
European Respiratory Journal 2023cited by 43position: middledoi
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
European Heart Journal 2022cited by 3,528position: middledoi
European Respiratory Society statement on long COVID follow-up
European Respiratory Journal 2022cited by 155position: middledoi
Improving lung health in low-income and middle-income countries: from challenges to solutions
The Lancet 2021cited by 466position: middledoi
Clinical standards for the assessment, management and rehabilitation of post-TB lung disease
The International Journal of Tuberculosis and Lung Disease 2021cited by 171position: middledoi
Screening for Tuberculosis in Migrants: A Survey by the Global Tuberculosis Network
Antibiotics 2021cited by 15position: middledoi
A European Respiratory Society technical standard: exhaled biomarkers in lung disease
European Respiratory Journal 2017cited by 626position: middledoi
MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation
Allergy 2015cited by 198position: middledoi
Integrated care pathways for airway diseases (AIRWAYS-ICPs)
European Respiratory Journal 2014cited by 170position: middledoi
Inhaled NO prevents hyperoxia-induced white matter damage in neonatal rats
Experimental Neurology 2013cited by 40position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Sofie Happaerts · KU Leuven1 papers (2023–2023) · 1 papers (2022–2022)Venerino Poletti · ENT and Allergy1 papers (2022–2022)Frits M.E. Franssen · University of Aveiro1 papers (2023–2023) · 1 papers (2013–2013)Michaël Staes · KU Leuven1 papers (2023–2023)Wim Janssens · KU Leuven1 papers (2023–2023) · 1 papers (2022–2022) · 1 papers (2023–2023)Hongyun Wang · Qingdao University1 papers (2024–2024)Nicola Sverzellati · St. Paul's Hospital1 papers (2022–2022)Olivier Baud · Université Claude Bernard Lyon 11 papers (2013–2013)Meng Wei · South China Agricultural University1 papers (2024–2024)Mingming Yin · Nantong University1 papers (2024–2024)Anne‐Marie Russell · Imperial College Healthcare NHS Trust1 papers (2022–2022)Jennifer K Quint · Imperial College London1 papers (2023–2023)Cuimei Zhao · Jilin University1 papers (2024–2024)Antonio Spanevello · Fudan University1 papers (2022–2022)Martin Witzenrath · German Centre for Cardiovascular Research1 papers (2022–2022)Sherif Gonem · University of Leicester1 papers (2023–2023)